Back
Essilorluxottica Vs. Innate Pharma SA Industry Stock Comparison
Buy
68
ESLOY
Essilorluxottica
Last Price:
123.44
Seasonality Move:
2.55%
Sell
29
IPHA
Innate Pharma SA
Last Price:
1.67
Seasonality Move:
8.67%
Buy
68
Essilorluxottica (ESLOY)
is a Buy
Is Essilorluxottica a Buy, Sell or Hold?
- The current Essilorluxottica [ESLOY] share price is $123.44. The Score for ESLOY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- ESLOY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $1.69. The Score for IPHA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESLOY Stock Price Chart
What is Essilorluxottica's stock price today?
-
The Essilorluxottica share price today is $123.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESLOY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESLOY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.34 | Buy |
| Relative Strength Index (14 RSI): | 61.83 | Buy |
| Chaikin Money Flow: | 123167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.44 - 122.12) | Buy |
| Bollinger Bands (100): | (110.91 - 120.01) | Buy |
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 4532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.65 - 1.97) | Sell |
| Bollinger Bands (100): | (1.9 - 2.3) | Sell |
ESLOY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.52 | Buy |
| 20-day SMA: | 120.19 | Buy |
| 50-day SMA: | 117.92 | Buy |
| 200-day SMA: | 112.51 | Buy |
| 8-day EMA: | 121.92 | Buy |
| 20-day EMA: | 120.57 | Buy |
| 50-day EMA: | 118.56 | Buy |
| 200-day EMA: | 112 | Buy |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.65 | Buy |
| 20-day SMA: | 1.77 | Sell |
| 50-day SMA: | 1.99 | Sell |
| 200-day SMA: | 2.31 | Sell |
| 8-day EMA: | 1.64 | Buy |
| 20-day EMA: | 1.76 | Sell |
| 50-day EMA: | 1.93 | Sell |
| 200-day EMA: | 2.25 | Sell |
Essilorluxottica Earnings Growth & ESLOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Essilorluxottica Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Innate Pharma SA Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||